Milestone Pharmaceuticals Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 28
Employees
  • Stock Symbol
  • MIST
Stock Symbol
  • Share Price
  • $7.15
  • (As of Monday Closing)

Milestone Pharmaceuticals General Information

Description

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.

Contact Information

Ownership Status
Publicly Held
Financing Status
Pending Transaction (M&A)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
  • 1111 Doctor.-Frederik-Philips Boulevard
  • Suite 420
  • Montreal, Quebec H4M 2X6
  • Canada
+1 (514) 000-0000

Milestone Pharmaceuticals Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Milestone Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.15 $7.14 $1.69 - $23.25 $177M 24.7M 4.91M -$2.35

Milestone Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV (8,379) 256,218
Revenue 0 0 0 0
EBITDA (62,397) (57,843) (23,812) (8,260)
Net Income (60,441) (55,229) (23,185) (8,086)
Total Assets 93,139 123,428 88,081 27,590
Total Debt 289 514 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Milestone Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Milestone Pharmaceuticals‘s full profile, request access.

Request a free trial

Milestone Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for t
Pharmaceuticals
Montreal, Canada
28 As of 2020
00000
000000000 00000

0000000

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
0000 000000000
New York, NY
0 As of 0000
000.00
000000000 000.00

0000 000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000 000000000
La Jolla, CA
00 As of 0000
00.000
000 0000-00-00
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Milestone Pharmaceuticals Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Relmada Therapeutics Formerly Angel backed New York, NY 0 000.00 000000000 000.00
0000 0000000000000 Venture Capital-Backed La Jolla, CA 00 00.000 00000000000 00.000
0000 000000000000 Formerly VC-backed Newton, MA 00 0000 000000000 - 0000
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
0000000 0000000000 Venture Capital-Backed Beijing, China 000 00000 00000000 00000
You’re viewing 5 of 33 competitors. Get the full list »

Milestone Pharmaceuticals Executive Team (12)

Name Title Board Seat Contact Info
Joseph Oliveto Chief Executive Officer & Board Member
Amit Hasija Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Jeff Nelson Chief Operating Officer
Lorenz Muller Executive
Guy Rousseau Ph.D Senior Vice President, Regulatory Affairs and Quality Management
You’re viewing 5 of 12 executive team members. Get the full list »

Milestone Pharmaceuticals Board Members (18)

Name Representing Role Since
Debra Liebert Domain Associates Board Member 000 0000
Joseph Oliveto Milestone Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Michael Tomsicek Self Board Member 000 0000
Paul Edick Self Chairman & Board Member 000 0000
Paul Truex Self Board Member 000 0000
You’re viewing 5 of 18 board members. Get the full list »

Milestone Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial